Posted in | News | Nanomaterials

Landa Digital Printing to Complete Development of Nanography with €100 Million Investment from ALTANA

The specialty chemicals Group ALTANA and Landa Corporation have concluded an equity financing agreement under which ALTANA will invest €100 million (~US$135 million) for a minority stake in Landa Digital Printing.

Both companies see the agreement not only as a financial investment, but also as a starting point for a long-term strategic partnership to bring digital printing solutions to the commercial, packaging and publishing markets. Other units of the Landa Group, including Landa Labs and Landa Ventures, are not included in the transaction.

The proceeds will be used for completing the development of Nanography, Landa's water-based digital printing process, including engineering and production ramp-up of Landa Nanographic Printing™ Presses and building of manufacturing plants for Landa NanoInk™ colorants.

ALTANA is expected to be an active partner, drawing on print industry expertise gained from its divisions including BYK Additives & Instruments, ECKART Effect Pigments, and ACTEGA Coatings & Sealants.

"We are extremely excited to be partnering with an industry visionary like Benny Landa. We speak the same language in terms of innovation," says Dr. Matthias L. Wolfgruber, CEO, ALTANA AG. "I am confident that we are investing in a game-changing technology that can enable the printing industry to thrive in the 21st century and help our customers position themselves well for the future."

"We see our alliance with the ALTANA Group as a key milestone for our company and a strong vote of confidence in our mission to bring digital printing to mainstream commercial, packaging and publishing markets," said Benny Landa, Chairman and CEO of Landa Corporation. "ALTANA brings a wealth of relevant industry and market experience as well as worldwide manufacturing expertise, which will be of great value as we expand our presence globally."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.